| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 77, 846-851, Copyright © 1993 by Endocrine Society
ARTICLES |
S Aeschimann, PA Kopp, ET Kimura, J Zbaeren, A Tobler, MF Fey and H Studer
Laboratories of Experimental Endocrinology, Inselspital, Berne, Switzerland.
Thirty-nine thyroid nodules, removed because of recent growth, were analyzed morphologically by serial histological sections for the classical histomorphological hallmarks of follicular cell replication and for immunohistochemically demonstrable overexpression of the growth- associated ras-gene product p21ras. Clonal analysis was performed using the highly informative probe M27 beta that detects polymorphisms on the locus DXS255 of the X-chromosome. Twenty-four nodules were of clonal and 15 nodules were of poly-clonal origin. Only 3 out of the 24 clonal nodules were histomorphologically uniform. In all others, the structural hallmarks of active growth and the P21ras growth-marker expression were remarkably heterogeneous throughout the tumors. There were no histomorphological characteristics distinguishing these clonal tumors from polyclonal nodules. Even if a clonal thyroid tumor may be originally homogeneous in respect to the parameters studied here, mechanisms must exist that create wide heterogeneity of growth and of morphogenetic potential among the individual follicular cells during further expansion of the nodule. Thus, clonal nodules are much more common in nodular goiters than hitherto assumed on grounds of the classical morphological criteria. The diagnosis of a true monoclonal nodule can no longer rely on morphological and functional criteria alone but requires molecular or cytogenetic analysis of clonality.
This article has been cited by other articles:
 |
|
 |
|
  J. A. Knauf, B. Ouyang, E. S. Knudsen, K. Fukasawa, G. Babcock, and J. A. Fagin Oncogenic RAS Induces Accelerated Transition through G2/M and Promotes Defects in the G2 DNA Damage and Mitotic Spindle Checkpoints J. Biol. Chem., February 17, 2006; 281(7): 3800 - 3809. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Krohn, D. Fuhrer, Y. Bayer, M. Eszlinger, V. Brauer, S. Neumann, and R. Paschke Molecular Pathogenesis of Euthyroid and Toxic Multinodular Goiter Endocr. Rev., June 1, 2005; 26(4): 504 - 524. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Diaz-Cano, M. de Miguel, A. Blanes, R. Tashjian, H. Galera, and H. J. Wolfe Clonality as Expression of Distinctive Cell Kinetics Patterns in Nodular Hyperplasias and Adenomas of the Adrenal Cortex Am. J. Pathol., January 1, 2000; 156(1): 311 - 319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Derwahl, M. Broecker, and Z. Kraiem Thyrotropin May Not Be the Dominant Growth Factor in Benign and Malignant Thyroid Tumors J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 829 - 834. [Full Text]
|
|
|
|
|
|
K. Krohn, D. Führer, H.-P. Holzapfel, and R. Paschke Clonal Origin of Toxic Thyroid Nodules with Constitutively Activating Thyrotropin Receptor Mutations J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 130 - 134. [Abstract] [Full Text]
|
|
|
|
|
|
P. G. Van Deerlin, N. Cekleniak, C. Coutifaris, J. Boyd, and J. F. Strauss III Evidence for the Oligoclonal Origin of the Granulosa Cell Population of the Mature Human Follicle J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 3019 - 3024. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Utiger Thyrotropin-Receptor Mutations and Thyroid Dysfunction N. Engl. J. Med., January 19, 1995; 332(3): 183 - 185. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
